Expresión de búsqueda: 1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE 
Descriptores Encontrados: 1
Mostrando: 1 .. 1  

 1 / 1 DeCS     
Descriptor Inglés:   1-Alkyl-2-acetylglycerophosphocholine Esterase 
Descriptor Español:   1-Alquil-2-acetilglicerofosfocolina Esterasa 
Descriptor Portugués:   1-Alquil-2-acetilglicerofosfocolina Esterase 
Sinónimos Inglés:   Lipoprotein-Associated Phospholipase A(2)
Lipoprotein-Associated Phospholipase A2
Lp-PLA(2)
Lp-PLA2
PAF 2-Acetylhydrolase
PAF 2-Acylhydrolase
PAF Acetylhydrolase II
Platelet-activating Factor Acetylhydrolase IB
1 Alkyl 2 acetylglycerophosphocholine Esterase
2-Acetylhydrolase, PAF
Acetylhydrolase II, PAF
Acetylhydrolase, PAF
Esterase, 1-Alkyl-2-acetylglycerophosphocholine
Factor Hydrolase, Platelet-Activating
Hydrolase, Platelet-Activating Factor
Lipoprotein Associated Phospholipase A2
Lp PLA2
PAF 2 Acetylhydrolase
PAF 2 Acylhydrolase
Phospholipase A2, Lipoprotein-Associated
Platelet Activating Factor Hydrolase
Platelet activating Factor Acetylhydrolase IB
PAF Acetylhydrolase
Platelet-Activating Factor Hydrolase  
Categoría:   D08.811.277.352.100.680.750.937.249
Definición Inglés:   A lipoprotein-associated PHOSPHOLIPASE A2 which modulates the action of PLATELET ACTIVATING FACTOR by hydrolyzing the SN-2 ester bond to yield the biologically inactive lyso-platelet-activating factor. It has specificity for phospholipid substrates with short-chain residues at the SN-2 position, but inactive against long-chain phospholipids. Deficiency in this enzyme is associated with many diseases including ASTHMA, and HYPERCHOLESTEROLEMIA. 
Nota de Indización Inglés:   /antag: coordinate with PHOSPHOLIPASE A2 INHIBITORS
Nota Histórica Inglés:   2004(1983) 
Calificadores Permitidos Inglés:  
AD administration & dosage AE adverse effects
AN analysis AI antagonists & inhibitors
BI biosynthesis BL blood
CF cerebrospinal fluid CS chemical synthesis
CH chemistry CL classification
CT contraindications DF deficiency
DE drug effects EC economics
GE genetics HI history
IM immunology IP isolation & purification
ME metabolism PK pharmacokinetics
PD pharmacology PH physiology
PO poisoning RE radiation effects
SE secretion ST standards
SD supply & distribution TU therapeutic use
TO toxicity UL ultrastructure
UR urine  
Número del Registro:   38141 
Identificador Único:   D043203 

Ocurrencia en la BVS:
 

Similar:

 
DeCS CID-10 SciELO LILACS LIS